8-K: AZEK Company Files Supplemental Proxy Disclosures Amid Shareholder Lawsuits Over James Hardie Merger

Sentiment:

Merger Update


The AZEK Company Inc. has filed supplemental disclosures to its definitive proxy statement for the upcoming merger with James Hardie Industries plc, addressing shareholder lawsuits alleging deficiencies in the original merger disclosures.

Delay expectedThe company is voluntarily making supplemental disclosures "in order to avoid the risk of the Demand Letters and the Stockholder Actions delaying the Merger."

Summary

  • The AZEK Company Inc. (AZEK) has filed a Form 8-K to provide supplemental disclosures related to its pending merger with James Hardie Industries plc.
  • This filing comes in response to several demand letters and two shareholder lawsuits (Ken Collins v. The AZEK Company Inc. et al. and Eric Johnson v. The AZEK Company Inc. et al., both filed June 9, 2025, in N.Y. Sup. Ct.) alleging deficiencies in the definitive proxy statement concerning the merger.
  • AZEK maintains that the allegations are without merit and no supplemental disclosures are legally required, but is voluntarily providing them to avoid delaying the merger and minimize associated expenses.
  • The supplemental disclosures amend and update financial information previously provided by Goldman Sachs in its opinion on the merger, including details on AZEK's standalone and combined company valuations.
  • Key financial figures updated include AZEK's total debt and cash as of December 31, 2024, and projected figures for fiscal years 2025-2028 for both AZEK standalone and the combined entity.
  • The document also amends the "Selected Transactions Analysis" table, providing updated enterprise values and EV/LTM Adjusted EBITDA multiples for comparable transactions.
  • The special meeting of stockholders to vote on the merger is scheduled for June 27, 2025.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the ongoing shareholder litigation and the necessity to file supplemental disclosures, which, while voluntary, indicates a response to perceived deficiencies. However, the company's denial of wrongdoing and proactive steps to avoid merger delays mitigate a stronger negative score.

Positives

  • The company is proactively addressing shareholder concerns by providing supplemental disclosures, aiming to avoid delays in the merger process.
  • Management believes the allegations in the lawsuits are without merit, suggesting confidence in the original disclosures.

Negatives

  • The company is facing shareholder litigation and demand letters alleging disclosure deficiencies regarding the merger.
  • The need for supplemental disclosures, even if voluntary, indicates a perceived weakness or vulnerability in the initial proxy statement.
  • Potential for additional similar demand letters or complaints, or amendments to existing lawsuits.

Risks

  • Required regulatory approvals for the Transaction or approval by AZEK's stockholders and other closing conditions may not be received or satisfied on a timely basis or at all.
  • Possible occurrence of events that may give rise to a right of either AZEK or James Hardie to terminate the merger agreement.
  • Possible negative effects of the announcement or consummation of the Transaction on the market price of James Hardie's and/or AZEK's shares and/or on their respective businesses, financial conditions, results of operations, and financial performance.
  • Impact of additional indebtedness the Company would incur in connection with the Transaction.
  • Risks relating to the value of the James Hardie shares to be issued in the Transaction and the contemplated listing arrangements.
  • Significant transaction costs and/or unknown liabilities.
  • Anticipated synergies and other benefits from the Transaction may not be realized in full or at all, or may take longer to realize than expected.
  • Risks associated with contracts containing consent and/or other provisions that may be triggered by the Transaction.
  • Risks associated with Transaction-related litigation, including potential delays or increased expenses.
  • Costs or difficulties related to the integration of AZEK's and James Hardie's businesses may be greater than expected.
  • The Transaction and its announcement could have an adverse effect on the parties' relationships with employees and other business partners, including suppliers and customers.
  • Potential for the Transaction to divert the time and attention of management from ongoing business operations.
  • Potential for contractual restrictions under the merger agreement to adversely affect the parties' ability to pursue other business opportunities or strategic transactions.
  • Risk of other Transaction-related disruptions to the businesses, including business plans and operations, of AZEK and James Hardie.
  • Possibility that James Hardie could lose its foreign private issuer status and be required to bear costs related to full compliance with U.S. domestic issuer rules.

Future Outlook

The document primarily focuses on addressing past disclosure deficiencies and does not provide new forward-looking guidance on operational performance or financial results beyond the previously disclosed merger-related projections. It reiterates the expectation of completing the merger, subject to regulatory and shareholder approvals, and the potential for realizing synergies, though these are subject to significant risks and uncertainties.

Management Comments

  • "The Company believes that the allegations contained in the Demand Letters and the Stockholder Actions are without merit."
  • "The Company believes that no supplemental disclosures are required under applicable laws; however, in order to avoid the risk of the Demand Letters and the Stockholder Actions delaying the Merger and to minimize the potential expense associated therewith, and without admitting any liability or wrongdoing, the Company is voluntarily making certain disclosures."
  • "To the contrary, the Company specifically denies all allegations in the Demand Letters and the Stockholder Actions, including that any additional disclosure was or is required."

Industry Context

This filing is specific to a merger transaction within the building products industry. The supplemental disclosures, particularly the updated selected transactions analysis, provide context on valuation multiples for M&A activities in the sector, indicating a range of enterprise value to LTM adjusted EBITDA multiples from 8.4x to 18.1x for comparable deals. The ongoing litigation highlights the increasing scrutiny on merger disclosures and corporate governance within the industry, emphasizing the importance of transparency and comprehensive information for shareholders in significant corporate transactions.

Comparison to Industry Standards

  • The "Selected Transactions Analysis" table provides specific comparable transactions and their valuation multiples (EV/LTM Adj. EBITDA):
  • LafargeHolcim's acquisition of Firestone Building Products Company, LLC (Jan 2021) at 12.6x.
  • Nucor Corporation's acquisition of Cornerstone Building Brands, Inc.'s Insulated Metal Panels Business (Jun 2021) at 10.0x (inclusive of expected synergies).
  • Westlake Chemical Corporation's acquisition of Boral Limited's North American Building Products Business (Jun 2021) at 10.5x.
  • Carlisle Companies Incorporated's acquisition of Henry Company (Jul 2021) at 13.2x.
  • KPS Capital Partners, LP's acquisition of Oldcastle BuildingEnvelope Inc. (Feb 2022) at 9.6x.
  • Clayton, Dubilier & Rice's acquisition of Cornerstone Building Brands, Inc. (Mar 2022) at 8.4x.
  • Nucor Corporation's acquisition of C.H.I. Overhead Doors (May 2022) at 13.0x.
  • CRH plc's acquisition of Barrette Outdoor Living (Jun 2022) at 10.0x.
  • Whirlpool Corporation's acquisition of InSinkErator (Aug 2022) at 18.1x.
  • Saint-Gobain's acquisition of Building Products of Canada Corp. (Jun 2023) at 11.9x.
  • MITER Brands' acquisition of PGT Innovations (Jan 2024) at 11.6x.
  • Owens Corning's acquisition of Masonite International Corporation (Feb 2024) at 8.6x.
  • These benchmarks provide a range of multiples against which the AZEK/James Hardie merger valuation could be assessed, although the document does not explicitly state the merger's implied multiple. The illustrative present values per share for AZEK standalone ($54 to $68) are provided for context.

Legal Proceedings

  • Several demand letters have been received from purported stockholders of the Company.
  • Two complaints have been filed: Ken Collins v. The AZEK Company Inc. et al., No. 653455/2025 (N.Y. Sup. Ct. filed June 9, 2025), and Eric Johnson v. The AZEK Company Inc. et al., No. 653502/2025 (N.Y. Sup. Ct. filed June 9, 2025).
  • These allege disclosure deficiencies and/or incomplete information regarding the Merger in the definitive proxy statement.
  • The Company believes the allegations are without merit and denies any additional disclosure was required, but is making voluntary supplemental disclosures to avoid delaying the Merger and minimize expense.
  • There is a possibility of additional similar demand letters or complaints, or amendments to existing complaints.

Stakeholder Impact

  • Shareholders: Directly impacted by the merger vote, the supplemental disclosures, and the ongoing litigation which questions the adequacy of information provided for their decision. The litigation could also affect the timing or terms of the merger.
  • Employees: Potential impact from the merger integration process, as well as potential distractions for management due to litigation.
  • Customers/Suppliers: Potential impact on relationships if the merger or its announcement causes disruptions.
  • Regulatory Authorities: The SEC is involved through the filing process and the effectiveness of the Form F-4.

Next Steps

  • The Company's special meeting of stockholders is scheduled for June 27, 2025, to vote on matters necessary to complete the Merger.
  • It is possible that additional, similar demand letters or complaints may be received or filed, or that the Stockholder Actions may be amended.
  • The Transaction is subject to required regulatory approvals and approval of AZEK's stockholders, and other conditions to closing.

Key Dates

DateDescription
2024-12-31Date for AZEK's total debt, debt-like items, cash, and cash equivalents used in Goldman Sachs' illustrative discounted cash flow analysis.
2025-03-19Date for AZEK's fully diluted outstanding shares and the combined company's fully diluted outstanding ordinary shares used in Goldman Sachs' analyses.
2025-03-23Original date of the Agreement and Plan of Merger between AZEK, James Hardie, and Juno Merger Sub Inc.
2025-05-04Date the Merger Agreement was amended.
2025-05-29Date James Hardie's registration statement on Form F-4 was declared effective by the SEC, and the definitive proxy statement/prospectus was sent to AZEK stockholders.
2025-06-09Date two shareholder complaints (Ken Collins v. The AZEK Company Inc. et al. and Eric Johnson v. The AZEK Company Inc. et al.) were filed in N.Y. Sup. Ct. regarding the merger.
2025-06-17Date of this Current Report on Form 8-K filing.
2025-06-27Date of the Company's special meeting of stockholders to vote on matters necessary to complete the Merger.
2025-09-30Illustrative closing date of the Transaction used in Goldman Sachs' combined company discounted cash flow analysis, and the date for illustrative equity values for fiscal years 2025-2028 in future share price analysis.

Recommendation

hold

Keywords

AZEK Company, James Hardie Industries, Merger Agreement, SEC Filing, Form 8-K, Proxy Statement, Shareholder Litigation, Disclosure Deficiencies, Financial Analysis, Goldman Sachs, Discounted Cash Flow, Enterprise Value, EBITDA, Building Products, Construction Materials, Corporate Governance, Risk Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.